Skip Navigation


CIT can broadcast your seminar, conference or meeting live to a world-wide audience over the Internet as a real-time streaming video. The event can be recorded and made available for viewers to watch at their convenience as an on-demand video or a downloadable podcast. CIT can also broadcast NIH-only or HHS-only content.

Age-Related Eye Disease Study (AREDS) News Conference

Loading video...

 
   
Air date: Friday, October 12, 2001, 10:00:00 AM
Time displayed is Eastern Time, Washington DC Local
Views: Total views: 105 * This only includes stats from October 2011 and forward.
Category: Special
Runtime: 00:28:49
Description: AMD and cataract are the leading causes of visual impairment and blindness in the United States. Based on many clinical studies, it is apparent that the frequency of both diseases increases dramatically after age 60. Although excellent treatments for cataract are available, there are no equivalent treatments for AMD. As the average lifespan of our population increases, the number of people who develop AMD will increase dramatically in the years ahead. Unless successful means of prevention or treatment are developed, blindness from AMD -- and its importance as a public health problem -- will increase.

For more information, visit
Age-Related Eye Disease Study
Debug: Show Debug
NLM Title: Age-related eye disease study (AREDS) news conference / Paul A. Sieving and Frederick L. Ferris III.
Author: Sieving, Paul A.
National Institutes of Health (U.S.)
Publisher:
Abstract: (CIT): AMD and cataract are the leading causes of visual impairment and blindness in the United States. Based on many clinical studies, it is apparent that the frequency of both diseases increases dramatically after age 60. Although excellent treatments for cataract are available, there are no equivalent treatments for AMD. As the average lifespan of our population increases, the number of people who develop AMD will increase dramatically in the years ahead. Unless successful means of prevention or treatment are developed, blindness from AMD -- and its importance as a public health problem -- will increase. For more information, visit Age-Related Eye Disease Study.
Subjects: Antioxidants--therapeutic use
Macular Degeneration--prevention & control
Zinc--therapeutic use
Publication Types: Webcasts
Rights: This is a work of the United States Government. No copyright exists on this material. It may be disseminated freely.
Download: To download this event, select one of the available bitrates:
[384k]    How to download a Videocast
NLM Classification: WW 270
NLM ID: 101267547
CIT Live ID: 1114
Permanent link: https://videocast.nih.gov/launch.asp?10350